Form 4 for FCX Freeport-McMoRan
Accepted 2021-12-06 00:00:00 ET · period of report 2021-08-13 · accession 0001209191-21-068186 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2021-12-06 | 2021-08-13 | FCX | ADKERSON RICHARD C | COB, CEO, Dir | G - Gift | $0.00 | -107.9K | 1.02M | -10% | $0 |
| DM | 2021-12-06 | 2021-12-02 | FCX | ADKERSON RICHARD C | COB, CEO, Dir | M - OptEx | $15.04 | +1.12M | 3.30M | +52% | +$16.91M |
| D | 2021-12-06 | 2021-12-06 | FCX | ADKERSON RICHARD C | COB, CEO, Dir | S - Sale+OE | $36.71 | -202.7K | 2.85M | -7% | -$7.44M |
| D | 2021-12-06 | 2021-12-02 | FCX | ADKERSON RICHARD C | COB, CEO, Dir | F - Tax | $37.10 | -718.8K | 3.06M | -19% | -$26.67M |
| DM | 2021-12-06 | 2021-12-02 | FCX | ADKERSON RICHARD C | COB, CEO, Dir | M - OptEx | $0.00 | -1.12M | 421.7K | -73% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-13 | G | D | 107,877 | $0.00 | 1,015,048 | I Through GRATs | — | — | (F2) Since the date of Mr. Adkerson's last Form 4, an aggregate 632,426 shares of the Issuer's Common Stock previously reported as directly held have been transferred to GRATs and are now reported as indirectly held. |
| 2 | Common | Common Stock | 2021-12-02 | M | A | 81,000 | $24.08 | 2,731,882 | D | — | — | (F2) Since the date of Mr. Adkerson's last Form 4, an aggregate 632,426 shares of the Issuer's Common Stock previously reported as directly held have been transferred to GRATs and are now reported as indirectly held. |
| 3 | Common | Common Stock | 2021-12-02 | M | A | 54,000 | $24.08 | 2,785,882 | D | — | — | |
| 4 | Common | Common Stock | 2021-12-06 | S | D | 202,701 | $36.71 | 2,853,582 | D | — | — | (F4) The price reported represents the weighted average price of the shares sold. Shares were sold at varying prices in the range of $36.4700 - $36.8950. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. (F5) Amount beneficially owned includes 1,109,000 RSUs, 1,000,000 of which are vested but deferred. |
| 5 | Common | Common Stock | 2021-12-02 | M | A | 263,333 | $11.87 | 3,564,215 | D | — | — | |
| 6 | Common | Common Stock | 2021-12-02 | M | A | 210,834 | $12.04 | 3,775,049 | D | — | — | |
| 7 | Common | Common Stock | 2021-12-02 | F | D | 718,766 | $37.10 | 3,056,283 | D | — | — | |
| 8 | Common | Common Stock | 2021-12-02 | M | A | 515,000 | $15.52 | 3,300,882 | D | — | — | |
| 9 | Derivative | Options (Right to Buy) | 2021-12-02 | M | D | 81,000 | $0.00 | 0 | D | $24.08 · 2013-02-06 to 2022-02-06 | 81,000 Common Stock | (F6) 25% exercisable on the date indicated and 25% exercisable on each of the three anniversaries thereof. |
| 10 | Derivative | Options (Right to Buy) | 2021-12-02 | M | D | 54,000 | $0.00 | 0 | D | $24.08 · 2012-02-06 to 2022-02-06 | 54,000 Common Stock | |
| 11 | Derivative | Options (Right to Buy) | 2021-12-02 | M | D | 515,000 | $0.00 | 0 | D | $15.52 · 2018-02-07 to 2027-02-07 | 515,000 Common Stock | (F6) 25% exercisable on the date indicated and 25% exercisable on each of the three anniversaries thereof. |
| 12 | Derivative | Options (Right to Buy) | 2021-12-02 | M | D | 263,333 | $0.00 | 131,667 | D | $11.87 · 2020-02-05 to 2029-02-05 | 263,333 Common Stock | (F7) 33% exercisable on the date indicated and 33% exercisable on each of the next two anniversaries thereof. |
| 13 | Derivative | Options (Right to Buy) | 2021-12-02 | M | D | 210,834 | $0.00 | 421,666 | D | $12.04 · 2021-02-04 to 2030-02-04 | 210,834 Common Stock | (F7) 33% exercisable on the date indicated and 33% exercisable on each of the next two anniversaries thereof. |